1. Home
  2. JAZZ vs ALK Comparison

JAZZ vs ALK Comparison

Compare JAZZ & ALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAZZ
  • ALK
  • Stock Information
  • Founded
  • JAZZ 2003
  • ALK 1932
  • Country
  • JAZZ Ireland
  • ALK United States
  • Employees
  • JAZZ N/A
  • ALK N/A
  • Industry
  • JAZZ Biotechnology: Pharmaceutical Preparations
  • ALK Air Freight/Delivery Services
  • Sector
  • JAZZ Health Care
  • ALK Consumer Discretionary
  • Exchange
  • JAZZ Nasdaq
  • ALK Nasdaq
  • Market Cap
  • JAZZ 6.5B
  • ALK 6.8B
  • IPO Year
  • JAZZ 2007
  • ALK N/A
  • Fundamental
  • Price
  • JAZZ $122.49
  • ALK $63.19
  • Analyst Decision
  • JAZZ Buy
  • ALK Strong Buy
  • Analyst Count
  • JAZZ 14
  • ALK 14
  • Target Price
  • JAZZ $173.93
  • ALK $63.71
  • AVG Volume (30 Days)
  • JAZZ 539.6K
  • ALK 2.5M
  • Earning Date
  • JAZZ 11-06-2024
  • ALK 01-23-2025
  • Dividend Yield
  • JAZZ N/A
  • ALK N/A
  • EPS Growth
  • JAZZ 458.10
  • ALK 24.49
  • EPS
  • JAZZ 7.04
  • ALK 2.51
  • Revenue
  • JAZZ $3,992,712,000.00
  • ALK $10,754,000,000.00
  • Revenue This Year
  • JAZZ $7.51
  • ALK $13.55
  • Revenue Next Year
  • JAZZ $6.82
  • ALK $21.99
  • P/E Ratio
  • JAZZ $17.38
  • ALK $25.19
  • Revenue Growth
  • JAZZ 5.23
  • ALK 3.88
  • 52 Week Low
  • JAZZ $99.06
  • ALK $32.62
  • 52 Week High
  • JAZZ $134.17
  • ALK $65.62
  • Technical
  • Relative Strength Index (RSI)
  • JAZZ 53.16
  • ALK 74.29
  • Support Level
  • JAZZ $121.22
  • ALK $62.03
  • Resistance Level
  • JAZZ $126.23
  • ALK $65.62
  • Average True Range (ATR)
  • JAZZ 2.83
  • ALK 1.76
  • MACD
  • JAZZ -0.23
  • ALK 0.73
  • Stochastic Oscillator
  • JAZZ 50.43
  • ALK 82.39

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About ALK Alaska Air Group Inc.

Alaska Air Group Inc operates two airlines, Alaska and Horizon in three operating segments. The Mainline segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico, and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements (CPA). The Horizon segment includes the capacity sold to Alaska under a CPA. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary and Mileage Plan passenger revenue.

Share on Social Networks: